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The technique of measuring transpulmonary pressure and respiratory airflow with manometry and pneumotachography using the
least mean squared analysis (LMS) has been used broadly in both preclinical and clinical settings for the evaluation of neonatal res-
piratory function during tidal volume breathing for lung tissue and airway frictionalmechanical propertiesmeasurements.Whereas
the technique of measuring respiratory function using the impulse oscillation technique (IOS) involves the assessment of the rela-
tionship between pressure and flowusing an impulse signal with a range of frequencies, requires less cooperation and providesmore
information on total respiratory system resistance (chest wall, lung tissue, and airways). The present study represents a preclinical
animal study to determine whether these respiratory function techniques (LMS and IOS) are comparable in detecting changes in
respiratory resistance derived from a direct pharmacological challenge.
1. Introduction
The use of animal models for studying respiratory mechanics
under airway challenge tests has led to a sudden increase
of information regarding the behavior of the different areas
of the respiratory system. Despite the large amount of re-
search in the adult and pediatric groups, we still lack signif-
icant knowledge in the neonatal subgroup.The present study
represents a preclinical animal study to determine whether
two respiratory function techniques are comparable in de-
tecting changes in respiratory resistance derived from a direct
pharmacological challenge.
The technique of measuring transpulmonary pressure
and respiratory airflow with esophageal manometry, airway
manometry, and pneumotachography has been previously
described [1]. Transpulmonary pressure derived from
proximal airway pressures and intrapulmonary esophageal
pressure detected from a water-filled catheter [2, 3] are
measured by differential pressure transducers. The airflow is
measured with a low dead-space volume pneumotachometer
and a differential pressure transducer.The leastmean squared
analysis (LMS) has been used broadly in both preclinical and
clinical settings for the evaluation of neonatal lung function
during tidal volume breathing [1, 4, 5].
The technique of measuring respiratory function using
forced oscillation technique (FOT), or impulse oscillometry,
involves the assessment of the relationship between pressure
and flow using a forced/impulse signal composed with a
range of frequencies. The response to this signal is called the
respiratory impedance, which is the frequency-dependent re-
lationship between transrespiratory pressure and flow. The
impedance of the respiratory system includes the respiratory
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resistance (𝑅rs) and the respiratory reactance. The 𝑅rs is the
component of the pressure-flow relationship of the pressure
oscillation that is in phase with the airflow; it is measured by
the forward sound impulse and includes the total resistance of
the respiratory system (chest wall, lung tissue, and airways).
The technique was introduced in the initial study conducted
by Dubois et al. in the 1950s [6].
Since then, many advances have been made in refining
and using this technique for clinical research. Further mod-
ification of the technique has included the introduction of a
computer friendly device that applies a respiratory pressure
impulse, the impulse oscillometry system (IOS), which differs
from the initial FOT in its setup. It uses signals lasting 5ms
and containing 5Hz harmonics up to 50Hz [7].
Multiple authors have published data using these oscil-
latory techniques for studies that evaluated airway and
respiratory tissue mechanic responses after airway challenges
in adolescents and children [8–16].The techniques differenti-
ated between proximal and distal airway obstruction and are
a sensitive approach to determine bronchial hyperreactivity.
In this regard, it has been demonstrated that oscillation does
not modify the airway smooth muscle tone [17].
Despite the variable use of reference values, the techni-
ques hold promise because the patients do not need to com-
plete respiratory maneuvers, measurements are taken during
quiet respiration, and invasive procedures (e.g., placement
of an esophageal balloon) are not required to measure the
resistance of the respiratory tract. Despite the amount of
past research to establish these techniques as valid methods
for assessment of respiratory function in both children and
infants [18–25], additional validation is required for the neo-
natal population.
Significant remodeling of the respiratory system occurs
even after birth in humans [26] and animals [27]; however,
when compared with adults, neonates/infants have an in-
creased upper airway resistance, increased lower airway resis-
tance, decreased lung volume, decreased efficiency of respira-
tory muscles, and increased chest wall compliance. Extrapo-
lation of outcomes regarding respiratory physiology-function
and pharmacological challenge is not feasible.
The neonatal subgroup has been the focus of recent
work, and published data supports the investigation of the
oscillometry assessment in the youngest patients, with some
technical modifications, which included the stimulation of
a minimum of 2-second breathing pause at the end of
inspiration using the Hering-Breuer inflation reflex (reflex
triggered to prevent overinflation of the lungs by creating an
apneic pause) in unsedated neonates by means of a shutter
valve and a face mask [28, 29]. The IOS approach in neonates
has not been validated against an accepted “gold standard”
technique of respiratory function measurement (i.e., the
use of an esophageal balloon to determine transpulmonary
pressures to separate the chest wall and lung components of
the resistance spectrum).
Appropriately, the development and validation of oscil-
lometry techniques for clinical use in neonates will allow
assessment of respiratory function in this group of patients
to accurately measure lung development, respiratory disease,
and the response to drug or therapeutic challenges. The
clinical applicability of the neonatal piglet model has been
extensively studied for developmental respiratory biological
processes and pre-clinical endpoints by our group [30] as
well as numerous other investigators [31–37]. However, to
validate this methodology for broad clinical use, we believe
that accurate in vivo testing (a neonatal animal model) of an
airway challenge is warranted.
Therefore, the main aims of this study were to detect
significant pharmacological increases in resistance (% of
change) with both respiratory function techniques and to
assess the level of agreement between them in detecting this
airway reactivity outcome.The overall study aim is to validate
the IOS technique as a noninvasive means of evaluating
respiratory mechanics in the neonatal setting through a
range of resistance values representing the airway and tissue
mechanical proprieties; this validation is to be compared
with an older technique that is still currently accepted as a
standard for respiratory mechanics evaluation but requires
patient cooperation and placement of an esophageal pressure
catheter [2].
To explore this gap in research, we conducted this
pilot study to investigate the hypothesis that the IOS (new
technique) could be interchangeably used to measure the
effects of airway reactivity in neonatal settings.
2. Methods and Materials
2.1. Animal Preparation and Instrumentation Protocol. Neo-
natal piglets (𝑛 = 8, 6.6 ± 0.8 kg, and 20 ± 1 days of age)
were anesthetized, intubated by tracheotomy, and allowed
to breathe spontaneously. Piglets were anesthetized initially
with two 1mL/kg intramuscular injections, separated by
10min, of an anesthesia cocktail (ketamine: 23mg/kg; ace-
promazine: 0.58mg/kg; xylazine: 0.8mg/kg [KAX]) adapted
from previously described piglet protocols [30, 38]. Local
anesthesia was delivered to the skin and soft tissues around
the surgical sites with 0.5% lidocaineHCl (4mg/kg). For ven-
ous access and arterial blood sampling, respectively, 5- or
8-French umbilical catheters were inserted into the external
jugular vein and carotid artery. A tracheotomy was perform-
ed to allow for continued spontaneous breathing through a
3.0- to 5.0-mm-ID endotracheal tube (ETT) (Hi-LoTM Jet
tube; Mallinckrodt, Saint Louis, MO, USA). The size of the
trachea in this model facilitated the use of a standard neo-
natal/pediatric ETT. The tracheotomy procedure was nec-
essary to ensure a tight seal for more accurate measures of
respiratory mechanics and to eliminate upper airway shunt-
ing and flow contribution.
Subsequent anesthesia was maintained with intravenous
infusion of KAX at 0.4mL/kg/hr. Maintenance fluid was
provided by a continuous venous infusion of 5% dextrose
solution at a rate of 6mL/kg/hr. Arterial blood pressure was
monitored by attaching the arterial catheter to a standard
pressure transducer via bedside patient monitor (model
M1175A, Hewlett Packard, Palo Alto, CA, USA). ECG elec-
trodes were also placed for monitoring the heart rate and
cardiac rhythm and to detect any significant bradycardia.
Throughout the protocol, the animal’s rectal temperature was
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monitored and maintained at 37-38∘C on a radiant warmer
bed (Resuscitaire; Hill-Rom Air-Shields, Hatboro, PA, USA).
Once the physiologic stability of the animal was confirmed
by the analysis of the arterial blood chemistry (Stat profile;
Nova Biomedical, Waltham, MA, USA), ECG, and blood
pressure monitoring; the animal’s respiratory measurements
were recorded as described below. Intravenous midazolam
was used as an anxiolytic to ease the work of breathing. Fol-
lowing the completion of the protocol, animals were eutha-
nized with pentobarbital (50mg/kg) and saturated potassium
chloride (2mEq). All procedures for the animal preparation
were approved by the Institutional Animal Care and Use
Committee. Functional respiratory parameters of interest
were recorded after the animal was stabilized.The piglet then
was connected to the PEDS circuit for baseline measure-
ments. Immediately following LMS baseline assessment
(average of 5min), the piglet was connected to the IOS system
for baseline oscillatory measurements, and testing was per-
formed as soon as the transrespiratory pressure returned to
10 cmH
2
O as described below. Also, Figure 1 illustrates the
test paradigm that was followed in order to compare res-
piratory function assessment between the LMS and IOS
methods both before and after pharmacologically induced
airway constriction.
2.2. Respiratory Function Assessment-Least Mean Squared
Analysis. For the conventional tidal breathing resistance
measurements, the ETT was connected to the pneumota-
chometer port. A three-valve stopcock was used to block the
pressure port. The negative flow port was manually occluded
to prevent flow artifact since there was no additional flow via
ventilator tubing. A water-filled balloon was placed via the
mouth into the esophagus to measure the intrathoracic pres-
sure during respiration. Optimum placement of the balloon
was confirmed by real-time monitoring of pressure tracings,
using criteria of maximum negative deflection during inspi-
ration with minimum cardiac artifacts. Only spontaneous
breaths (at least 10 breaths) were analyzed, and breaths with
distortion of the signal were excluded from the average data.
Piglets were observed for 30 seconds on the circuit. Res-
piratory volumeswere determinated by electronic integration
of flow signals, and the following parameters were calculated:
dynamic pulmonary resistance (𝑅) in cmH
2
O/L/s, respira-
tory rate, tidal volume, and minute ventilation. Resistance
values were recorded while positive pressure was applied
to induce opposition to flow and calculated by least mean
squared (LMS) algorithms incorporated into the computer
system.
2.3. Respiratory Function Assessment-Impulse Oscillometry
Analysis. The impedance of the total respiratory system was
measured using a commercially available IOS that has been
described previously. During tidal breathing through an ETT,
an impulse generator delivered brief pulses at intervals of
0.2 sec, superimposed on the spontaneous breathing pattern.
The digitalized pressure and flow signals were fed into the fast
Fourier transformation, where 32 samples were considered.
For experimental proposes, no system correction was used.
Pharmacologic challenge
Baseline PFT
LMS IOSLMS IOS
Post PFT
1 mg/kg/hr
BL 𝑁 = 7 𝑇0 2Time (hr)
Pig preparation and
stabilization period
(1 hr)
Bethanechol
1 mg/kg twice
infusion
Test paradigm
Figure 1: A schematic diagram illustrating the current test para-
digm. LMS, least mean squares; IOS, impulse oscillatory system;
PFT, pulmonary function testing; 𝑁, number of animals; BL, base-
line; Post, after bethanechol administration. Time between the first
and second bethanechol doses was 10min.
Daily calibration using a calibration pump (3.0 ± 0.01 L SD,
Jaeger; Ho¨echberg, Germany) and a reference impedance of
10 cmH
2
O/L/s were performed, and amaximum error of 10%
was permitted. Piglets were connected via ETT adapter to the
pneumotach of the IOS, were tested for 30 seconds on the cir-
cuit with a transrespiratory pressure of 10 cmH
2
O, and were
saved for later evaluation; epoch of measurements was dis-
carded if the time flow and pressure pattern in the primary
data time and time results trends showed interruption of the
oscillatory signal, which occurred occasionally (approxi-
mately 10–15%) in the current study. In the evaluation phase,
the minimum time period for reporting these measurements
was 2 seconds.The impedance of the respiratory system (𝑍rs)
and 𝑅rs in cmH2O/L/s were calculated at 3, 5, 10, 15, 20, 25,
and 35Hz. Replicate oscillatory values were performed by
JLAB 4.65.1.0 software (Erich Jaeger GmbH, Wu¨rzburg, Ger
many) and analyzed by JLAB 5.20.0.52 software (VIASYS
Healthcare GmbH, Ho¨echberg, Germany). Since parameters
were assessed within the same piglet over time/delta changes,
a correction for the impedance of the ETT was not needed.
Each piglet provided a matched set of data from the Mas-
terScreen PFT IOS (Jaeger, Ho¨echberg, Germany) and the
PEDS pulmonary function unit (MAS, Hatfield, PA) for the
oscillometry and LMS analyses, respectively. Each piglet was
measured with each device under two conditions: baseline
(pre) and after intervention (post).
Following baselinemeasures, bethanechol was used as the
intervention to pharmacologically induce bronchoconstric-
tion and subsequent elevated airway resistance. Bethanechol
powder (carbamyl-𝛽-methylcholine, Sigma-Aldrich) was
mixed with saline (5mg of bethanechol : 1mL of saline) and
administered as two intravenous injections at a dose of
1mg/kg of bethanechol chloride in 0.2mL/kg of saline set
10min apart to achieve an increase in the respiratory resis-
tance. Decay in the elevated resistance was compensated with
an infusion of 1mg/kg/hr of bethanechol chloride started
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through the venous line following the initial bolus. This dos-
ing regimen was adapted from a previously described piglet
protocol [30]. To compare the two methodologies described
herein, we were interested in establishing a large range of pul-
monary changes (baseline to maximum dose response with-
out evoking significant cardiovascular changes) instead of a
standard dose response assessment with small pulmonary
changes.
Bethanechol bolus and maintenance dose were given as
described above. Piglets were observed until stable broncho-
constriction was assumed (3–5min after the second dose)
when resistance increased at least 40% from baseline. Post-
intervention LMS measurements were obtained, followed by
IOS measurements, to prevent any unfavorable effect from
the impulses on LMS parameters. Parameters of interest
were documented for each technique, each time in the same
sequence.
2.4. Statistics. Continuous variables were summarized over-
all by mean and standard error of the mean (SEM), unless
indicated otherwise. All assumptions were tested for normal-
ity; in the case of violation of any assumption, nonparametric
tests were performed.Thedelta changeswere compared using
paired 𝑡-test for the dependent continuous normal variables
or Wilcoxon signed rank test for the nonnormal dependent
variables, testing for positive mean or median differences,
respectively. Significance was set at alpha level of 0.05 (1-
sided). A comparative analysis of agreement between the two
methods was detailed for the pharmacological challenge
using the Bland-Altman plot analysis; the bias, or the average
of the differences, and the 95% limits of agreement (LOA)
were reported for all frequencies along with their linear re-
gression analysis (𝑟2, slope, and 𝑃 values). Statistical analysis
was done using a combination of statistical software packages
(GraphPad Prism version 5.02 for Windows; GraphPad Soft-
ware, San Diego, CA, USA, and SPSS version 19; IBM, Chi-
cago, IL, USA).
3. Results
In this animal model, measurements of respiratory mechan-
ics were possible, and detection of an increase in resistance
was achieved with both systems after bethanechol adminis-
tration in seven of the piglets. One animal died during the
postbethanechol measurements (post) secondary to car-
diac arrest. Following intravenous (IV) administration of
bethanechol, a small but statistically significant decrease was
seen in heart rate (mean ± SD, 151 ± 12 versus 133 ± 6, −12%,
𝑃 = 0.03) and arterial pressure (mean ± SD, 79 ± 5 versus
67±5, −15%, 𝑃 = 0.002) for the remaining 7 piglets; although
these changes were not physiologically relevant for hemody-
namic instability, there were no significant changes in respi-
ratory rate, tidal volume, and minute ventilation following
bethanechol administration.
Respiratory mechanics measurements showed a signifi-
cant increase in dynamic pulmonary resistance measured by
the LMS (+53%, 𝑃 = 0.003) following bethanechol adminis-
tration (Figure 2). Pressure-volume loops also verified that,
when compared with baseline, bethanechol administration
resulted in increased pressure requirements as well as a
widening and decrease in the slope of the pressure-volume
loops.
Following bethanechol administration, a significant over-
all increase in the respiratory resistancemeasured by IOS was
demonstrated by positive changes in 𝑅rs from 10 to 25Hz
(+96%, 𝑃 = 0.018; Figure 3). Significant increases in speci-
fic respiratory resistances were demonstrated by positive
changes in the intermediate frequency spectrum (frequen-
cies: 𝑅rs 10Hz [+106%, 𝑃 = 0.031], 𝑅rs 15Hz [+96%, 𝑃 = 0.013],
𝑅rs 20Hz [+95%, 𝑃 = 0.026], and 𝑅rs 25Hz [+85%, 𝑃 = 0.037]).
No statistically significant differences between the pre-
bethanechol (pre) and postbethanechol (post) outcomes for
any remaining frequencies were observed:𝑅rs 3Hz (+67%,𝑃 =
0.131), 𝑅rs 5Hz (+67%, 𝑃 = 0.09), and 𝑅rs 35Hz (+95%, 𝑃 =
0.084), and the resistance spectrum of 𝑅rs demonstrated
increased positive frequency dependence (Figure 4).
The Bland-Altman analysis demonstrated that 95% of the
differences betweenmethods (IOS and LMS) lay within ±1.96
SD from the mean difference indicated by the LOA. Overall,
there was a consistent linear sloped trend with a systematic
bias (negative bias presented at lower values and positive
bias presented at higher values of the measurement range)
across theBland-Altmanplots, butwithin the LOA (Figure 5);
this effect becomes less biased towards lower frequencies
(Figures 5(a) and 5(b)) as do the slopes of the linear regression
analysis.
4. Discussion
In the present study, we demonstrated that both respiratory
function techniques assessed the effects of intravenous
bethanechol on the respiratory system. Our results showed
that delta changes of oscillometric resistances in the middle
frequency range (𝑅rs 10, 106%; 𝑅rs 15, 96%; 𝑅rs 20, 95%; 𝑅rs 25,
85%) were higher than LMS dynamic pulmonary resistance
(𝑅, 53%).
The smoothmuscle of the respiratory tract has both para-
sympathetic and sympathetic innervations; carbamyl-𝛽-
methylcholine (bethanechol) is a choline ester and an agonist
of muscarinic receptors that stimulates these receptors on the
smooth muscle of the respiratory tract, causing airway nar-
rowing and perhaps tissue constriction. Bethanechol belongs
to the same group of drugs as acetylcholine, carbachol, and
methacholine [39]. The piglet model used in this study was
chosen based on its comparable size to the neonate/pediatric
human and its common use for the investigation of ventila-
tory therapies [31–37].
In addition, bethanechol-induced airway challenges have
been previously reported as an appropriate experimental
intervention in the laboratory [40–44], and similar analogs
(i.e., methacholine) have been used for clinical research pur-
poses [45–47]. In humans, bethanechol is approved only for
oral administration use; in veterinary medicine, it is available
as an injection for subcutaneous (SC), intramuscular, or IV
administration. Cardiac arrest is a severe, rare adverse reac-
tion documented in humans, and in animals, it is a likely
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Figure 2: Plots of mean values for dynamic pulmonary resistance
(resistance) before (pre) and after (post) bethanechol for each piglet.
𝑃 = 0.003, paired 𝑡-test one tailed.
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Figure 3: Plots of mean values for respiratory resistance (𝑅rs) from
10Hz to 25Hz before (pre) and after (post) bethanechol for each
piglet. 𝑃 = 0.018, paired 𝑡-test one tailed for the average.
severe cholinergic reaction if given IV or in overdosage. It is
recommended that atropine be immediately available when
given IV or SC [48–51].
After bethanechol administration, a greater percentage of
change was seen in airway resistance mainly represented by
𝑅rs 10–𝑅rs 25 (+106–85%) when compared with the lung resist-
ance mostly represented by 𝑅rs 3–𝑅rs 5 (+69–63%), indicating
a greater nonperipheral airway constriction response than
peripheral airway/lung tissue response. Regarding the lung
tissue contribution versus airway contributions to the total
respiratory resistance, differences in the degree of tissue ver-
sus airway contribution exist between species [52, 53], includ-
ing humans [54], andwithin induced-physiological and phar-
macological conditions [44]; thus, caution should be taken in
translating these findings between species.
It is widely recognized that the use of an esophageal bal-
loon for resistance measurements separates the lung and
chest wall component, therefore, excluding the chest wall
resistance [4], while 𝑅rs includes the resistance of the chest
Post
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s
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H
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O
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Figure 4: Plots of mean (±SEM) values for respiratory resistance
(𝑅rs), as a function of oscillatory frequency, before (pre) and after
(post) bethanechol (𝑛 = 7). As shown, significant differences in
the middle oscillatory frequencies range are displayed ( ∗𝑃 < 0.05);
paired 𝑡-test one tailed at each frequency and overall (𝑃 = 0.0002).
wall (i.e., lung resistance) and airway resistance. The lower
the specific oscillatory frequency is, the more sensitive the
measurement is to the periphery of the respiratory system.
Measurement of the resistance using methods that require
placement of an esophageal balloon for respiratory function
testing procedures to assess the respiratory system in neo-
nates is not easy. Noninvasive respiratory function techniques
(i.e., impulse oscillometry) require less patient cooperation
and provide more information about the total respiratory
system resistance [19].
We also demonstrated that no pause in breathing was
necessary for recording reliable data at low frequencies for
𝑅rs using the impulse oscillation technique in neonatal piglets
spontaneously breathing through an ETT. In this regard, the
Hering-Breuer inflation reflex and face mask were not used
in our study in comparison to previously citied studies in un-
sedated neonates/infants [28, 29].
The Bland-Altman analysis showed good agreement bet-
ween the two techniques (IOS and LMS) formeasuring resist-
ance properties, and the agreement between these techniques
depended on the oscillation frequency. From a mechanistic
view point, 𝑅 measured by the LMS in the study represents
resistance of the lung tissue and airway frictional mechanical
properties, whereas 𝑅rs measured by IOS represents total res-
piratory resistance, so the two techniques are not directly
interchangeable at lower frequencies. However, as mentioned
in Section 3, the bias and slope decrease towards lower freq-
uencies. In this regard, respiratory resistance at 5Hz (𝑅rs 5)
and respiratory resistance at 3Hz (𝑅rs 3) may be closely
interchangeable in the appropriate settings. However, the
difference of ±1.96 SD from the mean difference for 𝑅rs 35
(Figure 5(g)) was demonstrated to be unacceptable for inter-
changeability.
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Figure 5: Bland-Altman plots constructed from the least mean square (LMS) and impulse oscillometry (IOS) data at each specific frequency
(percentage of change) withmean (bias), ±LOA, and best-fit values of linear regression (slope, 𝑟2, 𝑃 value) after administration of intravenous
bethanechol. LOA, limit of agreement; Upper LOA, mean difference (bias) + 1.96 SD; Lower LOA, mean difference (bias) −1.96 SD; 𝑟2, 𝑅
squares. The 𝑃 value is testing the null hypothesis that the overall slope is zero.
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Like many preliminary studies, the present study has
some experimental limitations. Along these lines, the current
study is an experimental preclinical model comparing the
IOS and the LMS approach as an indicator of airway reac-
tivity behavior to a pharmacologic intervention in a small
number of animals. Additional work is required in the perfor-
mance, reproducibility, and safety of the oscillation techni-
que, including validation and qualification as a biomarker,
before it can be proposed for standard clinical practice in the
neonatal population.
5. Conclusions
In conclusion, we documented significant airway reactivity
using both respiratory function techniques anddemonstrated
the magnitude of the change in airway resistance component
at baseline and after administration of intravenous bethane-
chol. In a similar scenario, the measurements of respiratory
resistance from the impulse oscillation technique (from 3Hz
to 25Hz)may be used in lieu of the dynamic pulmonary resis-
tance measurements from the LMS technique to determine
resistance changes secondary to induced airway reactivity
during spontaneous breaths.
The IOS technique as a noninvasive means of evaluating
the different components of the respiratory system and pul-
monarymechanics in the neonatal setting is very appealing; it
gives further information through a range of resistance values
representing the airway, tissue, and chest mechanical propri-
eties. However, further modification in the technique setup,
incorporation of the appropriate references values for the
neonatal population, and collaboration with experienced
physicians and scientists in respiratory physiology/respira-
tory function techniques are required before broader clinical
use is pursued in the neonatal population.
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